SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

NCT06737081 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: SAL-0951 tablets 4mg
DRUG: SAL-0951 tablets 5mg

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.